The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™

Calidi Biotherapeutics Inc. (NYSE American: CLDI)

Investment Considerations Calidi precisely delivers genetic medicines to cancer tumors and other sites of complex diseases. Calidi’s unique OV platforms are engineered to protect and amplify the virus – increasing efficacy and enhancing tumor targeting and patient safety, including through systemic application. Calidi’s lead programs include a drug candidate in a Phase 1 trial through … Continue reading “Calidi Biotherapeutics Inc. (NYSE American: CLDI)”

View Profile